Cleared Abbreviated

K111438 - REKA E100

K111438 is an FDA 510(k) clearance for REKA E100, manufactured by Reka Pte, Ltd.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Abbreviated 510(k) pathway after a 111-day FDA review.

K111438 · Reka Pte, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
111d
Days
Class 2
Risk

K111438 is an FDA 510(k) clearance for the REKA E100. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Reka Pte, Ltd. (Summerville, US). The FDA issued a Cleared decision on September 12, 2011 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Reka Pte, Ltd. devices

FDA 510(k) Submission Details - K111438

510(k) Number K111438 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2011
Decision Date September 12, 2011
Days to Decision 111 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 125d · This submission: 111d
Pathway characteristics
Standards-based clearance path.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 327
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K111438.
PAGEWRITER TC 20, 30, 50, 70
K113144 · Philips Medical Systems · Apr 2012
ELECTROCARDIOGRAPH
K120188 · Edan Instruments, Inc. · Mar 2012
CALG-STR EXERCISE ECG ANALYSIS ALGORITHM
K112959 · Philips Health Care · Jan 2012
ECG SERIES ELECTROCARDIOGRAPH
K111805 · Advanced Instrumentations, Inc. · Aug 2011
ECG-6 SERIES ELECTROCARDIOGRAPH
K112135 · Advanced Instrumentations, Inc. · Aug 2011
ACG-8511 PORTABLE ECG MONITOR
K110328 · Andon Health Co, Ltd. · Jul 2011